Addition Of A Bile Acid Sequestrant (WelChol, Colesevelam HCl) To Statin Therapy Significantly Reduces Median Hs-CRP Levels, Intitial Data Show

... Data published today in theApril 15 issue of the American Journal of Cardiology demonstrated thatadding WelChol(R) (colesevelam hydrochloride) to stable statin therapy(i.e. Zocor(R) (simvastatin), Lipitor(R) (atorvastatin calcium) orPravachol(R) (pravastatin sodium)) further reduced mean LDL-C, or "bad"cholesterol, and median high-sensitivity C-reactive protein (hs-CRP)levels... click link for more info. ...